[1. Jakupec MA, Galanski M, Keppler BK. Tumour-inhibiting platinum complexes-state of the art and future perspectives. Rev Physiol Biochem Pharmacol. 2003; 146: 1-53.10.1007/s10254-002-0001-x]Search in Google Scholar
[2. Wong E, Giandomenico CM. Current Status of Platinum- Based Antitumor Drugs. Chem. Rev. 1999; 99(9): 2451-66.]Search in Google Scholar
[3. Desoize B, Madoulet C. Particular aspects of platinum compound used at present in cancer treatment. Crit Rev Oncol Hematol. 2002; 42(3): 317-25.10.1016/S1040-8428(01)00219-0]Search in Google Scholar
[4. Rabik CA, Dolan ME. Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev. 2007; 33(1): 9-23.10.1016/j.ctrv.2006.09.006185522217084534]Search in Google Scholar
[5. Bugarcic ZD, Bogojeski J, Petrovic B, Hochreuther S, Eldik R. Mechanisitic studies on the reactions of platinum(II) complexes with nitrogen- and sulfur- donor biomolecules. Dalton Trans. 2012; 41(40): 12329-45.10.1039/c2dt31045g22890549]Search in Google Scholar
[6. Dasari S, Tchounwou PB. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol. 2014; 740: 364-78.10.1016/j.ejphar.2014.07.025414668425058905]Search in Google Scholar
[7. Schimmel KJM, Richel DJ, Van Den Brink RBA, Guchelaar HJ. Cardiotoxicity of cytotoxic drugs. Cancer Treat Rev. 2004; 30(2): 181-91.10.1016/j.ctrv.2003.07.00315023436]Search in Google Scholar
[8. Yao X, Panichpisal K, Kurtzman N, Nugent K. Cisplatin Nephrotoxicity: A Review. The Am J Med Sci. 2007; 334(2): 115-24.10.1097/MAJ.0b013e31812dfe1e17700201]Search in Google Scholar
[9. Miller PR, Tadagavadi RK, Ramesh G, Reeves WB. Mechanisms of Cisplatin Nephrotoxicty. Toxins. 2010; 2(11): 2490-518.10.3390/toxins2112490315317422069563]Search in Google Scholar
[10. Mc Whinney SR, Goldberg RM, Mc Leod HL. Platinum neurotoxicity pharmacogenetics. Mol Cancer Ther. 2009; 8(1): 10-6.10.1158/1535-7163.MCT-08-0840265182919139108]Search in Google Scholar
[11. Ding D, Allman BL, Salvi R. Review: Ototoxic Characteristics of Platinum Antitumor Drugs. Anat Rec (Hoboken). 2012; 295(11): 1851-67.10.1002/ar.2257723044998]Search in Google Scholar
[12. Chirino YI, Pedraza-Chaverri J. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp Toxicol Pathol. 2009; 61(3): 223-42. 10.1016/j.etp.2008.09.003]Search in Google Scholar
[13. Döring HJ, Dehnert H. The isolated perfused warmblooded heart according to Langendorff. In: Döring C (Ed.): Methods in Experimental Physiology and Pharmacology. Biological Measurement Techniques. Berlin, Germany: Biomesstechnik-Verlag, 1988: pp. 1-129]Search in Google Scholar
[14. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979; 95(2): 351-8.10.1016/0003-2697(79)90738-3]Search in Google Scholar
[15. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal Biochem. 1982; 126(1): 131-8.10.1016/0003-2697(82)90118-X]Search in Google Scholar
[16. Auclair C, Voisin E. Nitroblue tetrazolium reduction. In: Greenvvald Ra Hadnbook of methods for oxygen radical research. CRC Press Une, Boca Raton. 1985: 123-32.]Search in Google Scholar
[17. Pick E, Keisari Y. A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J immunol Methods. 1980: 38(1-2); 161-70.10.1016/0022-1759(80)90340-3]Search in Google Scholar
[18. Jordan P, Carmo-Fonesca M. Molecular mechanisms invoved in cisplatin cytotoxicity. Cell Mol. Life Sci. 2000; 57(8-9): 1229-35.10.1007/PL00000762]Search in Google Scholar
[19. Arola OJ, Saraste A, Pulkki K et al. Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res. 2000; 60(7): 1789-92.]Search in Google Scholar
[20. Icli F, Karaouguz H, Dincol D et al. Sever vascular toxicity associated with cisplatin-based chemotherapy. Cancer. 1993; 72(2): 587-93.10.1002/1097-0142(19930715)72:2<587::AID-CNCR2820720242>3.0.CO;2-V]Search in Google Scholar
[21. Dieckmann KP, Struss WJ, Budde U. Evidence for acute vascular toxicity of cisplatin-based chemotherapy in patients with germ cell tumour. Anticancer res. 2011; 31(12): 4501-6.]Search in Google Scholar
[22. Galanski M, Keppler BK. Synthesis and characterization of new ethylendiamine platinum(IV) complexes containg lipophilic carboxylate ligands. Metal Based Drugs. 1995; 2: 57-63. 10.1155/MBD.1995.57]Search in Google Scholar
[23. Pai VB, Nahata MC. Cardiotoxicity of chemotherapeutic agents. Drug Saf. 2000; 22(4): 263-302.10.2165/00002018-200022040-00002]Search in Google Scholar
[24. Ferroni P, Della-Monte D, Palmirotta R et al. Platinumbased compounds and risk for cardiovascular toxicity in the elderly: role of the antioxidants in chemoprevention. Rejuventation Res. 2011; 14(3): 293-308.10.1089/rej.2010.1141]Search in Google Scholar
[25. Al-Majed AA, Sayed-Ahmed AA, Al-Yahya AA, Aleisa AM, Al-Rejaie SS, Al-Shabanah OA. Propionyl-L-carnitine prevents the progression of cisplatin-induces cardiomyopathy in a carnitine-depleted rat model. Pharmacol Res. 2010; 53(3): 278-86.10.1016/j.phrs.2005.12.005]Search in Google Scholar
[26. Ma H, Jones KR, Guo R, Xu P, Shan Y, Ran J. Cisplatin compromises myocardial contractile function and mitochondrial ultrastructure: role of endoplasmic reticulum stress. Clin. Exp. Pharmacol. Physiol. 2010; 37(4): 460-5.]Search in Google Scholar
[27. Yousef MI, Saad AA, El-Shennawy LK. Protective effect of grape seed proanthocyanidin extract against oxidative stress induced by cisplatin in rats. Food Chem Toxicol. 2009; 47(6): 1176-83.10.1016/j.fct.2009.02.007]Search in Google Scholar
[28. Damian G. Deavall, Elizabeth A.Martin, Judith M. Horner, and Ruth Roberts. Drug-Induced Oxidative Stress and Toxicity. J Toxicol. 2012; 1-13.10.1155/2012/645460]Search in Google Scholar
[29. Yuce A, Atessahin A, Ceribasi AO, Aksakal M. Ellagic acid prevents cisplatin-induced oxidative stress in liver and heart tissue of rats. Basic Clin Pharmacol Toxicol. 2007; 101(5): 345-9.10.1111/j.1742-7843.2007.00129.x]Search in Google Scholar
[30. El-Sawalhi MM, Ahmed LA. Exploring the protective role of apocynin, a specific NADPH oxidase inhibitor, In cisplatin-induced cardiotoxicityin rats. Chem Biol Interact.2014; 207: 58-66.10.1016/j.cbi.2013.11.008]Search in Google Scholar
[31. Hussein A, Ahmed AAE, Shouman SA, Sharawy S. Ameliorating effect of DL-α-lipoic acid against cisplatin- induced nephrotoxicity and cardiotoxicity in experimental animals. Drug Discov Ther. 2012; 6(3): 147-56.10.5582/ddt.2012.v6.3.147]Search in Google Scholar
[32. Baek SM, Kwon CH, Kim JH, Woo JS, Jung JS, Kim YK. Differential roles of hydrogen peroxide and hydroxyl radical in cisplatin-induced cell death in renal proximal tubular epithelial cells. J Lab Clin Med 2003; 142(3): 178-86.10.1016/S0022-2143(03)00111-2]Search in Google Scholar
[33. Sawicka E, Długosz A, Jedrzejczyk J. Antioxidative Enzyme Activities after Exposure to KP972 and Cisplatin. Adv Clin Exp Med 2011; 591-7.]Search in Google Scholar
[34. Kadikoylu G, Bolaman Z, Demir S, Balkaya M, Akalin N, Enli Y. The effects of desferrioxamine on cisplatin induced lipid peroxidation and the activities of antioxidant enzymes in rat kidneys. Hum Exp Toxicol 2004; 23(1): 29-/34.10.1191/0960327104ht413oa15027813]Search in Google Scholar
[35. Cepeda V, Fuertes MA, Castilla J, Alonso C, Quevedo C, Perez JM. Biochemical Mechanisms of Cisplatin Cytotoxicity. Anticanc Anticancer Agents Med Chem. 2007; 7(1): 3-18.10.2174/18715200777931404417266502]Search in Google Scholar
[36. Martins NM, Santos NA, Curti C, Bianchi ML, Santos AC. Cisplatin induces mitochondrial oxidative stress with resultant energetic metabolism impairment, membrane rigidification and apoptosis in rat liver. J. Appl. Toxicol. 2008; 28(3): 337-44.]Search in Google Scholar
[37. Ko JW, Lee IC, Park SH. Protective effects of pine bark extract against cisplatininduced hepatotoxicity andoxidative stress in rats. Lab Anim Res. 2014; 30(4): 174-80.10.5625/lar.2014.30.4.174430670525628728]Search in Google Scholar
[38. Antunes LMG, Darin JDC, Bianchi MDL. Protective effects of vitamin C against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: a dosedependent study. Pharmacol Res. 2000; 41(4): 406-11.]Search in Google Scholar
[39. Ciftci O, Ozdemir I, Vardi N, Gurbuz N. Novel platinum- N-heterocyclic carbine complex is more cardiotoxic than cis-platin in rats. Hum Exp Toxicol. 2010; 30(9): 1342-9 10.1177/096032711039006421075807]Search in Google Scholar